Skip to main content
Equibles

FMR LLC

Position in ANIK — Anika Therapeutics, Inc.

CIK 315066 BOSTON, MA
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$775,097
+$77,343 QoQ
Shares Held
52,980
+10.1% QoQ
Ownership
0.396%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 134 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 40% Shared 0% None 60%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

FMR LLC holds $7,214,215,829 across 49 Drug Manufacturers - Specialty & Generic names. ANIK ranks #31 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 96,662,102 $1,534,994,177
2 ELAN
Elanco Animal Health Inc
 56,948,819 $1,401,510,433
3 HLN
Haleon plc
 120,991,250 $1,128,848,360
4 TEVA
Teva Pharmaceutical Industries Ltd
 30,258,016 $1,025,141,579
5 KNSA
Kiniksa Pharmaceuticals International, plc
 6,971,361 $445,818,534
6 LNTH
Lantheus Holdings, Inc.
 3,879,971 $430,443,982
7 AMLX
Amylyx Pharmaceuticals, Inc.
 16,727,909 $300,433,243
8 UTHR
UNITED THERAPEUTICS Corp
 473,409 $256,507,196

All Filings in ANIK

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $775,097 52,980
2026-03-31 $697,754 48,121
2025-12-31 $319,127 33,208
2025-09-30 $195,021 20,747
2025-06-30 $307,612 29,075
2025-03-31 $394,476 26,246
2024-12-31 $443,695 26,956
2024-09-30 $610,608 24,721
2024-06-30 $499,633 19,725
2024-03-31 $372,109 14,650
2023-12-31 $260,249 11,485
2023-09-30 $247,312 13,275
2023-06-30 $428,799 16,505
2023-03-31 $468,278 16,305
2022-12-31 $484,640 16,373
2022-09-30 $392,389 16,487
2022-06-30 $387,698 17,370
2022-03-31 $323,165 12,870
2021-12-31 $2,723 76
2021-09-30 $3,489 82
2021-06-30 $3,549 82
2021-03-31 $6,158 151
2020-12-31 $3,439 76
2020-09-30 $2,689 76
2020-06-30 $2,980 79
2020-03-31 $4,596 159